Dezheng Huo to Injections, Subcutaneous
This is a "connection" page, showing publications Dezheng Huo has written about Injections, Subcutaneous.
Connection Strength
0.061
-
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
Score: 0.061